Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Harvard Business School
Boehringer Ingelheim
Mallinckrodt
Colorcon

Last Updated: January 25, 2020

DrugPatentWatch Database Preview

Details for Biologics License Application: 103770

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Summary for BLA: 103770
Tradename:SYNAGIS
Applicant:Medimmune
Ingredient:palivizumab
Patents:124
Approval Date:Jun 19, 1998
Suppliers: see list1
Pharmacology for BLA: 103770

US Patents for BLA: 103770

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Medimmune SYNAGIS palivizumab VIAL 103770 001 1998-06-19   Start Trial WASHINGTON STATE UNIVERSITY (Pullman, WA) THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (Austin, TX) 2035-01-02 RX search
Medimmune SYNAGIS palivizumab VIAL 103770 001 1998-06-19   Start Trial ATOPIX THERAPEUTICS LIMITED (London, GB) 2034-05-02 RX search
Medimmune SYNAGIS palivizumab VIAL 103770 001 1998-06-19   Start Trial MedImmune Limited (Cambridge, GB) 2029-10-06 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Dow
Express Scripts
Mallinckrodt
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.